Returns the power, stopping probabilities, and expected sample size for testing rates in one or two samples at given maximum sample size.
Arguments
- design
The trial design. If no trial design is specified, a fixed sample size design is used. In this case, Type I error rate
alpha
, Type II error ratebeta
,twoSidedPower
, andsided
can be directly entered as argument where necessary.- ...
Ensures that all arguments (starting from the "...") are to be named and that a warning will be displayed if unknown arguments are passed.
- groups
The number of treatment groups (1 or 2), default is
2
.- riskRatio
If
TRUE
, the power for one-sided testing of H0:pi1 / pi2 = thetaH0
is calculated, default isFALSE
.- thetaH0
The null hypothesis value, default is
0
for the normal and the binary case (testing means and rates, respectively), it is1
for the survival case (testing the hazard ratio).
For non-inferiority designs,thetaH0
is the non-inferiority bound. That is, in case of (one-sided) testing ofmeans: a value
!= 0
(or a value!= 1
for testing the mean ratio) can be specified.rates: a value
!= 0
(or a value!= 1
for testing the risk ratiopi1 / pi2
) can be specified.survival data: a bound for testing H0:
hazard ratio = thetaH0 != 1
can be specified.count data: a bound for testing H0:
lambda1 / lambda2 = thetaH0 != 1
can be specified.
For testing a rate in one sample, a value
thetaH0
in (0, 1) has to be specified for defining the null hypothesis H0:pi = thetaH0
.- pi1
A numeric value or vector that represents the assumed probability in the active treatment group if two treatment groups are considered, or the alternative probability for a one treatment group design, default is
seq(0.2, 0.5, 0.1)
(power calculations and simulations) orseq(0.4, 0.6, 0.1)
(sample size calculations).- pi2
A numeric value that represents the assumed probability in the reference group if two treatment groups are considered, default is
0.2
.- directionUpper
Logical. Specifies the direction of the alternative, only applicable for one-sided testing; default is
TRUE
which means that larger values of the test statistics yield smaller p-values.- maxNumberOfSubjects
maxNumberOfSubjects > 0
needs to be specified for power calculations or calculation of necessary follow-up (count data). For two treatment arms, it is the maximum number of subjects for both treatment arms.- allocationRatioPlanned
The planned allocation ratio
n1 / n2
for a two treatment groups design, default is1
. For multi-arm designs, it is the allocation ratio relating the active arm(s) to the control. For simulating means and rates for a two treatment groups design, it can be a vector of lengthkMax
, the number of stages. It can be a vector of lengthkMax
, too, for multi-arm and enrichment designs. In these cases, a change of allocating subjects to treatment groups over the stages can be assessed. Note that internallyallocationRatioPlanned
is treated as a vector of lengthkMax
, not a scalar.
Value
Returns a TrialDesignPlan
object.
The following generics (R generic functions) are available for this result object:
names()
to obtain the field names,print()
to print the object,summary()
to display a summary of the object,plot()
to plot the object,as.data.frame()
to coerce the object to adata.frame
,as.matrix()
to coerce the object to amatrix
.
Details
At given design the function calculates the power, stopping probabilities, and expected sample size
for testing rates at given maximum sample size.
The sample sizes over the stages are calculated according to the specified information rate in the design.
In a two treatment groups design, additionally, an allocation ratio = n1 / n2
can be specified
where n1
and n2
are the number of subjects in the two treatment groups.
If a null hypothesis value thetaH0 != 0 for testing the difference of two rates
or thetaH0 != 1
for testing the risk ratio is specified, the
formulas according to Farrington & Manning (Statistics in Medicine, 1990) are used (only one-sided testing).
Critical bounds and stopping for futility bounds are provided at the effect scale
(rate, rate difference, or rate ratio, respectively).
For the two-sample case, the calculation here is performed at fixed pi2 as given as argument in the function.
Note that the power calculation for rates is always based on the normal approximation.
How to get help for generic functions
Click on the link of a generic in the list above to go directly to the help documentation of
the rpact
specific implementation of the generic.
Note that you can use the R function methods
to get all the methods of a generic and
to identify the object specific name of it, e.g.,
use methods("plot")
to get all the methods for the plot
generic.
There you can find, e.g., plot.AnalysisResults
and
obtain the specific help documentation linked above by typing ?plot.AnalysisResults
.
See also
Other power functions:
getPowerCounts()
,
getPowerMeans()
,
getPowerSurvival()
Examples
if (FALSE) { # \dontrun{
# Calculate the power, stopping probabilities, and expected sample size in a
# two-armed design at given maximum sample size N = 200 in a three-stage
# O'Brien & Fleming design with information rate vector (0.2,0.5,1),
# non-binding futility boundaries (0,0), i.e., the study stops for futility
# if the p-value exceeds 0.5 at interm, and allocation ratio = 2 for a range
# of pi1 values when testing H0: pi1 - pi2 = -0.1:
getPowerRates(getDesignGroupSequential(informationRates = c(0.2, 0.5, 1),
futilityBounds = c(0, 0)), groups = 2, thetaH0 = -0.1,
pi1 = seq(0.3, 0.6, 0.1), directionUpper = FALSE,
pi2 = 0.7, allocationRatioPlanned = 2, maxNumberOfSubjects = 200)
# Calculate the power, stopping probabilities, and expected sample size in a single
# arm design at given maximum sample size N = 60 in a three-stage two-sided
# O'Brien & Fleming design with information rate vector (0.2, 0.5,1)
# for a range of pi1 values when testing H0: pi = 0.3:
getPowerRates(getDesignGroupSequential(informationRates = c(0.2, 0.5,1),
sided = 2), groups = 1, thetaH0 = 0.3, pi1 = seq(0.3, 0.5, 0.05),
maxNumberOfSubjects = 60)
} # }